Welcome to the UK Antimicrobial Registry (UKAR)

The UK Antimicrobial Registry (UKAR) has been developed by the British Society for Antimicrobial Chemotherapy (BSAC) in collaboration with the University of Aberdeen (UoA) Epidemiology Team to provide prescribers and organisations the opportunity to capture real world usage of antimicrobial agents and identify where the real clinical unmet need lies. This will provide an invaluable resource for future research studies and also enable the sharing of best practice.

UKAR will support the antimicrobial community in increasing positive outcomes for patients while helping to contain and control the threat of antimicrobial resistance. The study will collects information on the use of recently launched intravenous antibiotics, with a particular focus on those used to treat infections due to multi-drug resistant organisms.

The study is funded by the British Society for Antimicrobial Chemotherapy (BSAC), supported by Pfizer, MENARINI Group, and Shionogi Europe, the UKAR study is helping us better understand how new antibiotics are used in real-world settings and strengthening antimicrobial stewardship across the UK. The study is open to all supporters and companies interested in joining the study should contact Tracey Guise, Deputy CEO, for an initial discussion.

UKAR is overseen by the multi-stakeholder Steering Committee that comprises clinicians appointed by BSAC to provide infection expertise along with the academic team to ensure appropriate consent and governance at all levels of implementation. Dr Jacqueline Sneddon is Programme Manager for this work and representatives from industry partners are also invited to inform the study as it progresses.

Following development of data requirements, build of the UKAR online database and agreement of the research questions that the study will answer, the study has secured over 1,100 patients from across 60 sites, with recruitment ongoing. Open recruitment of hospital sites from early 2023 has provided an exciting opportunity for hospitals across the UK to be part of a programme with national and international importance – publication on the results of the first 20 months of recruitment can be viewed here UK Antimicrobial Registry (UKAR): an overview of the first 20 months of recruitment | JAC-Antimicrobial Resistance | Oxford Academic

Full and further information is available via the UoA website

If your hospital is interested in getting involved in the UKAR project please visit the UoA website.